Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4163124
Max Phase: Preclinical
Molecular Formula: C17H16N2O3S
Molecular Weight: 328.39
Molecule Type: Small molecule
Associated Items:
ID: ALA4163124
Max Phase: Preclinical
Molecular Formula: C17H16N2O3S
Molecular Weight: 328.39
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C=CCN1C(=O)C(=C/C=C/c2ccco2)C(=O)N(CC=C)C1=S
Standard InChI: InChI=1S/C17H16N2O3S/c1-3-10-18-15(20)14(9-5-7-13-8-6-12-22-13)16(21)19(11-4-2)17(18)23/h3-9,12H,1-2,10-11H2/b7-5+
Standard InChI Key: IQOFCWFWJDEJCL-FNORWQNLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 328.39 | Molecular Weight (Monoisotopic): 328.0882 | AlogP: 2.55 | #Rotatable Bonds: 6 |
Polar Surface Area: 53.76 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.17 | CX LogD: 3.17 |
Aromatic Rings: 1 | Heavy Atoms: 23 | QED Weighted: 0.35 | Np Likeness Score: -0.92 |
1. Ramisetti SR, Pandey MK, Lee SY, Karelia D, Narayan S, Amin S, Sharma AK.. (2018) Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells., 143 [PMID:29133035] [10.1016/j.ejmech.2017.11.006] |
Source(1):